Anna E. Hosman

482 total citations
17 papers, 288 citations indexed

About

Anna E. Hosman is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Marketing. According to data from OpenAlex, Anna E. Hosman has authored 17 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 14 papers in Pulmonary and Respiratory Medicine and 5 papers in Marketing. Recurrent topics in Anna E. Hosman's work include Vascular Anomalies and Treatments (16 papers), Tracheal and airway disorders (13 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Anna E. Hosman is often cited by papers focused on Vascular Anomalies and Treatments (16 papers), Tracheal and airway disorders (13 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Anna E. Hosman collaborates with scholars based in Netherlands, United Kingdom and Canada. Anna E. Hosman's co-authors include Repke J. Snijder, Claire L. Shovlin, Johannes J. Mager, C. J. J. Westermann, Marco C. Post, F. J. M. Disch, Martijn C. Post, Marie E. Faughnan, Christine L. Mummery and Veronique M.M. Vorselaars and has published in prestigious journals such as The Lancet, Circulation and International Journal of Molecular Sciences.

In The Last Decade

Anna E. Hosman

17 papers receiving 279 citations

Peers

Countries citing papers authored by Anna E. Hosman

Since Specialization

Citations

This map shows the geographic impact of Anna E. Hosman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Hosman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Hosman more than expected).

Fields of papers citing papers by Anna E. Hosman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna E. Hosman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Hosman. The network helps show where Anna E. Hosman may publish in the future.

Co-authorship network of co-authors of Anna E. Hosman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna E. Hosman. A scholar is included among the top collaborators of Anna E. Hosman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna E. Hosman. Anna E. Hosman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Conservative Pulmonary Arteriovenous Malformation Screening in Children: Re‐Evaluation of Safety 2025 ·Pediatric Pulmonology ·(unknown), (unknown), Anna E. Hosman, (unknown), Marco C. Post, (unknown), (unknown)	1
2	Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology 2021 ·International Journal of Molecular Sciences ·(unknown), Anna E. Hosman, Johannes J. Mager, Repke J. Snijder, Marco C. Post	20
3	Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study 2020 ·Angiogenesis ·(unknown), Repke J. Snijder, Anna E. Hosman, (unknown), F. J. M. Disch, Martijn C. Post, (unknown)	14
4	Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence 2020 ·Journal of Clinical Medicine ·(unknown), (unknown), Anna E. Hosman, Johannes C. Kelder, Martijn C. Post, Repke J. Snijder, Johannes J. Mager	21
5	Prevalence and diagnostic value of nail fold capillary microscopy in hereditary hemorrhagic telangiectasia: A retrospective study 2020 ·Vascular Medicine ·(unknown), Veronique M.M. Vorselaars, Anna E. Hosman, Martijn C. Post, Repke J. Snijder, Johannes J. Mager	1
6	The use of echo density to quantify pulmonary right-to-left shunt in transthoracic contrast echocardiography 2020 ·European Heart Journal - Cardiovascular Imaging ·(unknown), (unknown), (unknown), Anna E. Hosman, Martin J. Swaans, Repke J. Snijder, (unknown), Marco C. Post	3
7	Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia 2018 ·Netherlands Heart Journal ·(unknown), Sebastiaan Velthuis, (unknown), Anna E. Hosman, C. J. J. Westermann, Repke J. Snijder, Johannes J. Mager, Martijn C. Post	7
8	Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2 2018 ·Circulation ·(unknown), (unknown), Anna E. Hosman, Sabrina Martín, Noël Lamandé, (unknown), (unknown), (unknown), Hetty C. de Boer, Simon Tual‐Chalot, (unknown), Helen M. Arthur, Yihai Cao, Repke J. Snijder, F. J. M. Disch, Johannes J. Mager, Ton J. Rabelink, Christine L. Mummery, Karine Raymond, Franck Lebrin	27
9	Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia 2018 ·International Journal of Molecular Sciences ·Veronique M.M. Vorselaars, Anna E. Hosman, Cornelis J.J. Westermann, Repke J. Snijder, Johannes J. Mager, Marie‐José Goumans, Marco C. Post	30
10	Executive summary of the 12th HHT international scientific conference 2017 ·Angiogenesis ·Jillian W. Andrejecsk, Anna E. Hosman, Luisa M. Botella, Claire L. Shovlin, Helen M. Arthur, Sophie Dupuis‐Girod, Elisabetta Buscarini, Christopher C.W. Hughes, Franck Lebrin, Christine L. Mummery, Marco C. Post, Johannes J. Mager	8
11	Screening children for pulmonary arteriovenous malformations: Evaluation of 18 years of experience 2017 ·Pediatric Pulmonology ·Anna E. Hosman, (unknown), (unknown), (unknown), C. J. J. Westermann, Repke J. Snijder, Marco C. Post, Johannes J. Mager	21
12	Life expectancy of parents with Hereditary Haemorrhagic Telangiectasia 2016 ·Orphanet Journal of Rare Diseases ·(unknown), (unknown), Anna E. Hosman, C. J. J. Westermann, Repke J. Snijder, Marie E. Faughnan, (unknown)	38
13	Follow-up of Thalidomide treatment in patients with Hereditary Haemorrhagic Telangiectasia 2015 ·Rhinology Journal ·Anna E. Hosman, C. J. J. Westermann, Repke J. Snijder, F. J. M. Disch, Christine L. Mummery, Johannes J. Mager	19
14	Evaluation of anticoagulant and antiplatelet use in a haemorrhagic disorder 2014 ·The Lancet ·(unknown), Anna E. Hosman, (unknown), Claire L. Shovlin	1
15	Acute sinusitis and blindness as the first presentation of chronic lymphocytic leukaemia. 2014 ·PubMed ·(unknown), (unknown), Eduard J. van Beers, Anna E. Hosman, M P Mourits, C. J. M. van Noesel, (unknown), S.M. Reinartz	1
16	Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls 2013 ·Orphanet Journal of Rare Diseases ·Anna E. Hosman, (unknown), (unknown), Claire L. Shovlin	28
17	Lifestyle and Dietary Influences on Nosebleed Severity in Hereditary Hemorrhagic Telangiectasia 2013 ·The Laryngoscope ·(unknown), Anna E. Hosman, (unknown), Claire L. Shovlin	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact